Methods, Systems, And Apparatuses For Perforating Tissue Structures

Patent No. US12343074 (titled "Methods, Systems, And Apparatuses For Perforating Tissue Structures") was filed by Atraverse Medical Inc on Feb 16, 2024.

What is this patent about?

’074 is related to the field of medical devices, specifically electrosurgical systems used for tissue perforation, particularly in cardiac interventions like transseptal puncture. The background involves the need to create passageways through tissue structures to access treatment sites, such as puncturing the atrial septum to reach the left side of the heart. Existing systems have drawbacks like unwanted injury, char formation, complicated connections, and high manufacturing costs.

The underlying idea behind ’074 is to improve the safety and efficiency of tissue perforation by using a guidewire with a variable current density profile . This is achieved by strategically placing an insulating collar near the distal tip and exposing a conductive outer region as the guidewire extends beyond an insulating sheath. The initial high current density at the tip facilitates tissue puncture, while the subsequent reduction in current density minimizes the risk of unintended tissue damage.

The claims of ’074 focus on a method of using a guidewire with an insulating sheath. The method involves extending the guidewire's distal tip a first distance to contact a septum, delivering RF energy to perforate the septum, and then further extending the tip a second distance. This second extension exposes both an insulating collar and a conductive outer region, which reduces the RF current density around the tip.

In practice, the guidewire is advanced through a patient's vasculature within an insulating sheath until it reaches the target tissue, such as the atrial septum. The guidewire is then extended a short distance to expose the distal tip, which delivers concentrated RF energy to create a puncture. As the guidewire is advanced further, the insulating collar and conductive outer region are exposed, effectively increasing the conductive surface area and reducing the current density at the tip. This prevents excessive heating and potential damage to surrounding tissues after the initial puncture.

This design differentiates from prior approaches by actively managing the current density profile during the procedure. Traditional electrosurgical devices often maintain a constant current density, which can lead to unintended tissue damage after the initial puncture. By strategically exposing a conductive outer region and using an insulating collar, ’074 provides a self-regulating mechanism that enhances safety and control during tissue perforation. The insulating collar ensures that the current density at the distal tip remains high enough to penetrate the septum, while the conductive outer region reduces the current density to prevent lesions in the heart wall.

How does this patent fit in bigger picture?

Technical landscape at the time

In the early 2020s when ’074 was filed, medical devices commonly relied on radiofrequency (RF) energy delivery for tissue perforation during procedures such as transseptal puncture. At a time when such systems were typically implemented using guidewires and catheters, a key engineering constraint was preventing unwanted injury to other areas of the heart from inadvertent perforation or lead to char or thrombus formation due to high operating temperatures.

Novelty and Inventive Step

The examiner approved the claims because the prior art, whether considered individually or in combination, did not disclose or make obvious a method involving a guidewire with a distal tip, a conductive outer region, and an insulating collar within an insulating sheath. Specifically, the prior art failed to teach a guidewire including a conductive outer region and an insulating collar disposed between the distal tip and the conductive outer region in combination with the other limitations.

Claims

This patent contains 19 claims, with claim 1 being the only independent claim. Independent claim 1 is directed to a method of using a guidewire with an insulating sheath to create a perforation in the septum of a heart using radiofrequency energy. The dependent claims generally elaborate on and refine the method of independent claim 1, adding details regarding tenting the septum, dilating the perforation, using a surgical instrument, electrosurgical interface, monitoring and modulating RF energy, and specific characteristics of the insulating collar and conductive outer region.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
Conductive outer region
(Claim 1)
“In one embodiment, a guidewire includes a distal tip and a conductive core coupled to the distal tip. the guidewire further includes a conductive outer region disposed near, and coupled to, the distal tip and an insulating collar disposed between the distal tip and the conductive outer region. The guidewire is distally extendable out of an insulating shaft by a first distance in which the distal tip is exposed without exposing the conductive outer region, the guidewire when extended the first distance being configured to deliver RF energy via the distal tip to tissue to perforate the tissue. The guidewire is distally extendable out of the insulating shaft by a second distance greater than the first distance in which the distal tip and at least a portion of the conductive outer region are exposed, such that an exposed surface area of the portion of the conductive outer region is configured to reduce a RF current density around the distal tip”A conductive portion of the guidewire, located near the distal tip, that is exposed when the guidewire is extended a second distance, and which reduces RF current density around the distal tip.
Distal tip
(Claim 1)
“In one embodiment, a guidewire includes a distal tip and a conductive core coupled to the distal tip. The conductive core is configured to deliver to the distal tip radiofrequency (RF) current from a generator coupled to a proximal portion of the guidewire. The guidewire is distally extendable out of an insulating shaft by a first distance in which the distal tip is exposed without exposing the conductive outer region, the guidewire when extended the first distance being configured to deliver RF energy via the distal tip to tissue to perforate the tissue.”The end of the guidewire that delivers RF energy to perforate tissue.
Insulating collar
(Claim 1)
“Fifth, the guidewire used in systems described herein can have an insulating collar that allows for the tip of the guidewire to direct RF energy during therapy.”A non-conductive portion of the guidewire disposed between the distal tip and the conductive outer region.
Insulating sheath
(Claim 1)
“In one embodiment, a system includes an insulating shaft including a proximal end and a distal end and defining a lumen therethrough, and a guidewire configured to be slidably disposed within the lumen. The guidewire is configured to be advanced distally relative to the insulating shaft to expose a distal tip of the guidewire, the distal tip of the guidewire, when exposed, configured to deliver radiofrequency (RF) energy to a septum of a subject to perforate the septum.”A non-conductive covering that houses the guidewire and allows for controlled extension of the distal tip.
RF current density
(Claim 1)
“The guidewire is distally extendable out of the insulating shaft by a second distance greater than the first distance in which the distal tip and at least a portion of the conductive outer region are exposed, such that an exposed surface area of the portion of the conductive outer region is configured to reduce a RF current density around the distal tip”The concentration of radiofrequency current around the distal tip, which is reduced by exposing the conductive outer region.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

US12343074

ATRAVERSE MEDICAL INC
Application Number
US18444623
Filing Date
Feb 16, 2024
Status
Granted
Expiry Date
Dec 27, 2043
External Links
Slate, USPTO, Google Patents